Found: 13
Select item for more details and to access through your institution.
Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02526-y
- By:
- Publication type:
- Article
Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL-rearranged AML.
- Published in:
- Science Signaling, 2016, v. 9, n. 445, p. 1, doi. 10.1126/scisignal.aad8243
- By:
- Publication type:
- Article
Type 2 nitric oxide synthase and protein nitration in chronic lung infection.
- Published in:
- Journal of Pathology, 2003, v. 199, n. 1, p. 122, doi. 10.1002/path.1256
- By:
- Publication type:
- Article
Pharmacologic ATM but not ATR kinase inhibition abrogates p21-dependent G1 arrest and promotes gastrointestinal syndrome after total body irradiation.
- Published in:
- Scientific Reports, 2017, p. 41892, doi. 10.1038/srep41892
- By:
- Publication type:
- Article
Relevance of ATM Status in Driving Sensitivity to DNA Damage Response Inhibitors in Patient-Derived Xenograft Models.
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4195, doi. 10.3390/cancers15164195
- By:
- Publication type:
- Article
A microfluidic system that replicates pharmacokinetic (PK) profiles in vitro improves prediction of in vivo efficacy in preclinical models.
- Published in:
- PLoS Biology, 2022, v. 20, n. 5, p. 1, doi. 10.1371/journal.pbio.3001624
- By:
- Publication type:
- Article
Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 325, p. 1, doi. 10.1126/scitranslmed.aad2355
- By:
- Publication type:
- Article
pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Late Intervention with a Myeloperoxidase Inhibitor Stops Progression of Experimental Chronic Obstructive Pulmonary Disease.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2012, v. 185, n. 1, p. 34, doi. 10.1164/rccm.201103-0468OC
- By:
- Publication type:
- Article
Mixed effects modeling of radiotherapy in combination with immune checkpoint blockade or inhibitors of the DNA damage response pathway.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 11, p. 1640, doi. 10.1002/psp4.13026
- By:
- Publication type:
- Article
Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models.
- Published in:
- 2020
- By:
- Publication type:
- journal article
ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
ALT neuroblastoma chemoresistance due to telomere dysfunction–induced ATM activation is reversible with ATM inhibitor AZD0156.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 607, p. 1, doi. 10.1126/scitranslmed.abd5750
- By:
- Publication type:
- Article